Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Cancer. 2018 Feb 20;124(9):1973–1981. doi: 10.1002/cncr.31286

Figure 3. Survival of patients diagnosed with PF- D3 RMS.

Figure 3

Overall survival and event-free survival was determined for 24 individuals diagnosed with PF- D3 RMS (median followup time of 1.8 years; range: 0.4 to 4.5 years).